Erica C Leifheit1, Yun Wang2, George Howard2, Virginia J Howard2, Larry B Goldstein2, Thomas G Brott2, Judith H Lichtman2. 1. From the Department of Chronic Disease Epidemiology (E.C.L., J.H.L.), Yale School of Public Health, New Haven, CT; Department of Biostatistics (Y.W.), Harvard T.H. Chan School of Public Health, Boston, MA; Departments of Biostatistics (G.H.) and Epidemiology (V.J.H.), School of Public Health, University of Alabama-Birmingham; Department of Neurology (L.B.G.), University of Kentucky College of Medicine and Kentucky Neuroscience Institute, Lexington; and Department of Neurology (T.G.B.), Mayo Clinic, Jacksonville, FL. erica.leifheit@yale.edu. 2. From the Department of Chronic Disease Epidemiology (E.C.L., J.H.L.), Yale School of Public Health, New Haven, CT; Department of Biostatistics (Y.W.), Harvard T.H. Chan School of Public Health, Boston, MA; Departments of Biostatistics (G.H.) and Epidemiology (V.J.H.), School of Public Health, University of Alabama-Birmingham; Department of Neurology (L.B.G.), University of Kentucky College of Medicine and Kentucky Neuroscience Institute, Lexington; and Department of Neurology (T.G.B.), Mayo Clinic, Jacksonville, FL.
Abstract
OBJECTIVE: To determine whether patients who are dual eligible for Medicare and Medicaid benefits have outcomes after carotid endarterectomy (CEA) that are comparable to the outcomes of those eligible for Medicare alone. METHODS: The study cohort included fee-for-service Medicare beneficiaries ≥65 years of age who underwent CEA (ICD-9-CM code 38.12) between 2003 and 2010. Beneficiaries with ≥1 month of Medicaid coverage were considered dual eligible. We fit mixed models to assess the relationship between coverage (dual eligible vs Medicare only) and outcomes over time after adjustment for demographic and clinical characteristics. RESULTS: There were 53,773 dual-eligible and 452,182 Medicare-only beneficiaries hospitalized for CEA. The percentage of dual-eligible patients receiving CEA increased from 10.1% in 2003 to 11.5% in 2010, with no change in geographic distribution across the country. In adjusted analyses, dual-eligible vs Medicare-only beneficiaries had a higher rate of 30-day ischemic stroke or death; higher in-hospital, 30-day, and 1-year all-cause mortality; and higher 30-day all-cause readmission. Relative annual reductions in outcomes from 2003 to 2010 ranged from 2% to 5%, but there was no significant interaction between dual-eligible status and time. CONCLUSIONS: Dual-eligible beneficiaries had worse outcomes than those eligible for Medicare alone. Additional work is necessary to understand the reasons for this difference.
OBJECTIVE: To determine whether patients who are dual eligible for Medicare and Medicaid benefits have outcomes after carotid endarterectomy (CEA) that are comparable to the outcomes of those eligible for Medicare alone. METHODS: The study cohort included fee-for-service Medicare beneficiaries ≥65 years of age who underwent CEA (ICD-9-CM code 38.12) between 2003 and 2010. Beneficiaries with ≥1 month of Medicaid coverage were considered dual eligible. We fit mixed models to assess the relationship between coverage (dual eligible vs Medicare only) and outcomes over time after adjustment for demographic and clinical characteristics. RESULTS: There were 53,773 dual-eligible and 452,182 Medicare-only beneficiaries hospitalized for CEA. The percentage of dual-eligible patients receiving CEA increased from 10.1% in 2003 to 11.5% in 2010, with no change in geographic distribution across the country. In adjusted analyses, dual-eligible vs Medicare-only beneficiaries had a higher rate of 30-day ischemic stroke or death; higher in-hospital, 30-day, and 1-year all-cause mortality; and higher 30-day all-cause readmission. Relative annual reductions in outcomes from 2003 to 2010 ranged from 2% to 5%, but there was no significant interaction between dual-eligible status and time. CONCLUSIONS: Dual-eligible beneficiaries had worse outcomes than those eligible for Medicare alone. Additional work is necessary to understand the reasons for this difference.
Authors: K H J Ultee; F Bastos Gonçalves; S E Hoeks; E V Rouwet; E Boersma; R J Stolker; H J M Verhagen Journal: Eur J Vasc Endovasc Surg Date: 2015-08-10 Impact factor: 7.069
Authors: Jacob A Doll; Anne S Hellkamp; Abhinav Goyal; Nadia R Sutton; Eric D Peterson; Tracy Y Wang Journal: JAMA Cardiol Date: 2016-10-01 Impact factor: 14.676
Authors: Judith H Lichtman; Michael R Jones; Erica C Leifheit; Alice J Sheffet; George Howard; Brajesh K Lal; Virginia J Howard; Yun Wang; Jeptha Curtis; Thomas G Brott Journal: JAMA Date: 2017-09-19 Impact factor: 56.272
Authors: Juliet Addo; Luis Ayerbe; Keerthi M Mohan; Siobhan Crichton; Anita Sheldenkar; Ruoling Chen; Charles D A Wolfe; Christopher McKevitt Journal: Stroke Date: 2012-02-23 Impact factor: 7.914
Authors: Oliver Y Tang; Ross A Clarke; Krissia M Rivera Perla; Kiara M Corcoran Ruiz; Steven A Toms; Robert J Weil Journal: J Neurooncol Date: 2022-01-13 Impact factor: 4.130
Authors: Linxin Li; Lucy E Binney; Samantha Carter; Sergei A Gutnikov; Sally Beebe; Karen Bowsher-Brown; Louise E Silver; Peter M Rothwell Journal: J Am Heart Assoc Date: 2019-07-03 Impact factor: 5.501